AlterSanté

Recent papers from AlterSanté

1. Assessing the relationship between structural characteristics, profitability, and extra-financial performance in a French pig farming networkAgricultural Systems · 2026
2. Standardized Infliximab Regimen to Treat Severe Central Nervous System Tuberculosis: A Case Series of 18 PatientsOpen Forum Infectious Diseases · 2025
3. Treatment outcomes of extensively drug-resistant tuberculosis in Europe: a retrospective cohort studyThe Lancet Regional Health - Europe · 2025
4. Real-world telemonitoring and remote support for home non-invasive ventilation to improve therapy effectiveness: the exploratory, multicentre randomised eVENT studyThorax · 2025
5. What are the outcomes for long-term survivors after esophagectomy ? – Evidence from a randomized controlled trial (FFCD9901)European Journal of Surgical Oncology · 2025
6. Use of putative hepatoprotective agents as an adjunct to anti-TB treatment in EuropeSHILAP Revista de lepidopterología · 2025
7. Development of Clinically Viable Non-Muscle Myosin II Small Molecule Inhibitors with Broad Therapeutic Potential2024
8. The prevention school diary: Evaluability assessment of a widely adopted intervention in Ile-de-FranceDeleted Journal · 2024
9. Incidence and risk factors of prolonged grief in relatives of patients with terminal cancer in French palliative care units: The Fami-Life multicenter cohort studyPalliative & Supportive Care · 2023
10. Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006–2019Emerging infectious diseases · 2022
11. Availability and costs of medicines for the treatment of tuberculosis in EuropeClinical Microbiology and Infection · 2022
12. Association Between Increased Linezolid Plasma Concentrations and the Development of Severe Toxicity in Multidrug-Resistant Tuberculosis TreatmentClinical Infectious Diseases · 2022
13. Anxiety and Depression in Chronic Obstructive Pulmonary Disease: Perspectives on the Use of HypnosisFrontiers in Psychology · 2022
14. Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: A TBnet and ESGMYC studyJournal of Infection · 2022
15. Co-administration of treatment for rifampicin-resistant tuberculosis and chronic hepatitis C virus infection: a TBnet and ESGMYC study2021
16. Improvement of HIV-associated neurocognitive disorders after antiretroviral therapy intensification: the Neuro+3 studyJournal of Antimicrobial Chemotherapy · 2020
17. Hypnosis for the Management of Anxiety and Dyspnea in COPD: A Randomized, Sham-Controlled Crossover TrialInternational Journal of COPD · 2020
18. Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, FranceEmerging infectious diseases · 2020
19. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 casesEuropean Respiratory Journal · 2020
20. Outcomes of Prolonged Mechanical Ventilation Before and After Implementation of a Respiratory ICURespiratory Care · 2020